Introduction: Jiangsu Yabang Pharmaceutical Group is formed by Yabang Chemical Group since 2002, has acquired Changzhou Third Pharmaceutical Factory, Jiangsu Linhai Pharmaceutical Company Limited, Yancheng Epson Pharmaceutical Company Limited, Yancheng Shengyuan Pharmaceutical Company Limited and other four state-owned pharmaceutical factories; Jintan Pharmaceutical Company, Ringshui Pharmaceutical Company and other pharmaceutical companies, and set up in Nanjing and Changzhou on the basis of the formation of the two Institute of Medicine. Since 2003, the company has been established successively. Since 2003, it has set up Anhui Yabang Health Products Company, Changzhou Yabang Pharmacy Co. The group and its subsidiaries have a registered capital of RMB 290 million, total assets of RMB 620 million, 1,650 employees and an area of 300,000 square meters. 2004 sales exceeded RMB 500 million, with an annual growth rate of 50%. Jiangsu Yabang Pharmaceutical Group mainly produces and sells western pharmaceutical raw materials and hundreds of varieties in twelve dosage forms, such as large-volume injections, small-volume injections, tablets, granules, capsules, oral liquids, eye drops, ointments, suspensions, syrups and so on. The business scope of the Pharmaceutical Company includes the purchase and sale of proprietary Chinese medicines, Chinese herbal medicines, Chinese medicinal tablets, chemical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products (except vaccines), the purchase and sale of Class I and Class II medical devices, the purchase and sale of aerosol insecticides, ether, alcohol (for medical use), turpentine, ringworm medicated products, pharmaceutical and health care products, hygienic materials and dressings, and detergents, and so on, with nearly 10,000 varieties. Pharmaceutical Group has more than 30 post-doctoral, doctoral and master's degree senior professionals; every year, it researches and develops more than 20 new drugs by itself and cooperates in the development of new drugs, and it is one of the pharmaceutical enterprises in China that invests the most in the research and development of new drugs and puts into production the most new drugs and generic drug types. Since 2002, the Group has invested more than 200 million yuan in the reconstruction of all the acquired pharmaceutical factories and companies, and by the end of 2004, all of them had passed the GMP and GSP certification.
Legal representative: Yang Jianze
Establishment date: 2001-01-17
Registered capital: RMB 40 million
Region: Jiangsu
Unified social credit code: 91320921703859698E
Operating status: active
Industry: manufacturing
The company is a member of the Pharmaceutical Group. Industry: Manufacturing
Company Type: Limited Liability Company (Wholly Owned by Legal Person)
English Name: Jiangsu Aipusen Pharmaceutical Co.,Ltd.
Personnel Size: 100-500
Enterprise Address: Yancheng City, Yanshou County, Xiangshui County City, Economic Development Zone
Business scope: hard capsules, tablets, granules, eye drops production and sales of the company's own products; self-support and agent of all kinds of goods and technology import and export business (except for state-restricted enterprises or prohibited the import and export of goods and technology). (Items subject to approval by law, can only carry out business activities after approval by the relevant departments)